Pfizer to Pay up to $2.9 Billion in Cancer Drug Deal With Merck of Germany CHAD BRAY The alliance between the American and German companies is expected to strengthen Merck’s oncology business in several important markets, including the United States. November 17, 2014 at 12:00AM http://nyti.ms/1vhojvO The New York Times Business Day Cancer, Drugs (Pharmaceuticals), Medicine and Health, Mergers, Acquisitions and Divestitures

By CHAD BRAY via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1vhojvO Pfizer to Pay up to $2.9 Billion in Cancer Drug Deal With Merck of Germany November 17, 2014 at 12:00AM The New York Times